{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:10:10Z","timestamp":1785863410882,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10815-014-0300-6","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T10:14:37Z","timestamp":1407924877000},"page":"1311-1316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients"],"prefix":"10.1007","volume":"31","author":[{"given":"Budi","family":"Wiweko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Maidarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Dwi","family":"Priangga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Shafira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanadi","family":"Sumapraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharam","family":"Natadisastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andon","family":"Hestiantoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"300_CR1","first-page":"485","volume":"12","author":"L Speroff","year":"2005","unstructured":"Speroff L. Clinical gynecologic endocrinology and infertility. Lippincott Williams. 2005;12:485\u2013513.","journal-title":"Lippincott Williams"},{"key":"300_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rigp.2005.04.001","volume":"5","author":"AU Bako","year":"2005","unstructured":"Bako AU, Morad S, Atiomo WA. Polycystic ovary syndrome: an overview. Rev Gynecol Pract. 2005;5:115\u201322.","journal-title":"Rev Gynecol Pract"},{"key":"300_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE\/ASRM","year":"2004","unstructured":"ESHRE\/ASRM. ESHRE\/ASRM rotterdam consensus meeting revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum. Reprod."},{"issue":"2","key":"300_CR4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","volume":"92","author":"F Fruzzetti","year":"2009","unstructured":"Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril. 2009;92(2):626\u201334.","journal-title":"Fertil. Steril."},{"key":"300_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","volume":"90","author":"I Streuli","year":"2008","unstructured":"Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90:395\u2013400.","journal-title":"Fertil. Steril."},{"issue":"1","key":"300_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Brincat M, et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92(1):240\u20135.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"300_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/09513590701485212","volume":"23","author":"S Weerakiet","year":"2007","unstructured":"Weerakiet S, Lertvikool S, Tingthanatikul Y, Wansumrith S, Leelaphiwat S, Jultanmas R. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling. Gynecol Endocrinol. 2007;23(8):455\u201360.","journal-title":"Gynecol. Endocrinol."},{"issue":"11","key":"300_CR8","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","volume":"24","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Yates AP, Roberts SA. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non obese subfertile women with and without polycystic ovary syndrome. Hum Reprod. 2009;24(11):2917\u201323.","journal-title":"Hum. Reprod."},{"key":"300_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mefs.2010.08.005","volume":"15","author":"AF Begawy","year":"2010","unstructured":"Begawy AF, El-Mazny AN, Salem NA, Taweel NE. Anti-mullerian hormone in polycystic ovary syndrome and normo-ovulatory women: correlation with clinical, hormonal and ultrasonographic parameters. Middle East Fert Soc J. 2010;15:253\u20138.","journal-title":"Middle East Fert Soc J"},{"issue":"9","key":"300_CR10","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly D, Pigny P, Soudan B, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab. 2010;95(9):4399\u2013405.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"300_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","volume":"158","author":"P Ska\u0142ba","year":"2011","unstructured":"Ska\u0142ba P, Cygal A, Madej P, D\u0105bkowska-Hu\u0107 A, Sikora J, et al. Is the plasma anti-mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol. 2011;158:254\u20139.","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"300_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9:505\u201314.","journal-title":"Hum. Reprod. Update"},{"key":"300_CR13","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","volume":"91","author":"MK Murphy","year":"2006","unstructured":"Murphy MK, Hall JE, Adams JM, Lee H, Welt CK. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:3878\u201384.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"300_CR14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","volume":"19","author":"AG Mulders","year":"2004","unstructured":"Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod. 2004;19:2036\u201342.","journal-title":"Hum. Reprod."},{"issue":"3","key":"300_CR15","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.fertnstert.2009.07.148","volume":"92","author":"EB Johnstone","year":"2009","unstructured":"Johnstone EB, Rousseau JA, Lamb JD, Huddleston HG, Cedars MI. Age bias in polycystic ovary syndrome (PCOS) diagnostic criteria limits diagnosis among those at greatest cardiovascular risk. Fertil Steril. 2009;92(3):S38.","journal-title":"Fertil. Steril."},{"issue":"11","key":"300_CR16","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","volume":"95","author":"EB Johnstone","year":"2010","unstructured":"Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R, et al. The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab. 2010;95(11):4965\u201372.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"300_CR17","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","volume":"20","author":"T Piltonen","year":"2005","unstructured":"Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod. 2005;20:1820\u20136.","journal-title":"Hum. Reprod."},{"issue":"6","key":"300_CR18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Normal RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"Hum. Reprod. Update"},{"key":"300_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","volume":"77","author":"CL Cook","year":"2002","unstructured":"Cook CL, Siow Y, Brenner AG, Fallat ME. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril. 2002;77:141\u20136.","journal-title":"Fertil. Steril."},{"key":"300_CR20","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Margalioth EJ, Gal M, Ben-Chetrit A, Algur N, Zylber-Haran E, et al. Serum anti-mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20:1814\u20139.","journal-title":"Hum. Reprod."},{"key":"300_CR21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","volume":"82","author":"A Marca La","year":"2004","unstructured":"La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, De Leo V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82:970\u20132.","journal-title":"Fertil. Steril."},{"key":"300_CR22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.2006.02533.x","volume":"64","author":"A Marca La","year":"2006","unstructured":"La Marca A, Volpe A. Anti-mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64:603\u201310.","journal-title":"Clin. Endocrinol."},{"key":"300_CR23","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1210\/jc.2006-2425","volume":"92","author":"DS Wachs","year":"2007","unstructured":"Wachs DS, Coffler MS, Malcom PJ, Chang RJ. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. J Clin Endocrinol Metab. 2007;92:1871\u20134.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"300_CR24","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","volume":"20","author":"T Piltonen","year":"2005","unstructured":"Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod. 2005;20:1820\u20136.","journal-title":"Hum. Reprod."},{"issue":"5","key":"300_CR25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","volume":"139","author":"L Pellat","year":"2010","unstructured":"Pellat L, Rice S, Mason HD. Anti mullerian hormone and polycystic ovary syndrome : a mountain to high? Reproduction. 2010;139(5):825\u201333.","journal-title":"Reproduction"},{"issue":"11","key":"300_CR26","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/humrep\/dep271","volume":"24","author":"SA Amner","year":"2009","unstructured":"Amner SA, Li TC, Ledger WL. The value of measuring anti mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy. Hum Reprod. 2009;24(11):2760\u20136.","journal-title":"Hum. Reprod."},{"issue":"1","key":"300_CR27","first-page":"77","volume":"196","author":"JG Wang","year":"2007","unstructured":"Wang JG, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. Mullerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am J Obstet Gynecol. 2007;196(1):77. e1-5.","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"300_CR28","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.fertnstert.2008.03.034","volume":"91","author":"T Singer","year":"2009","unstructured":"Singer T, Barad DH, Weghofer A. Correlation of antimullerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril June. 2009;91(6):2616\u20139.","journal-title":"Fertil Steril June"},{"issue":"2","key":"300_CR29","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1152\/ajpendo.90684.2008","volume":"300","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Macut D, et al. Anti mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;300(2):e238\u201343.","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"300_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","volume":"89","author":"JSE Laven","year":"2004","unstructured":"Laven JSE, Mulders AGMGJ, Visser JA, Themmen AP, de Jong FH, Fauser BCJM. Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004;89:318\u201323.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"300_CR31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:941\u20135.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"300_CR32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","volume":"96","author":"YH Lin","year":"2011","unstructured":"Lin YH, Chiu WC, Wu CH, Tzeng CR, Sen Hsu C, Hsu MI. Antimullerian hormone and polycystic ovary syndrome. Fertil Steril. 2011;96(1):230\u20135.","journal-title":"Fertil. Steril."},{"issue":"10","key":"300_CR33","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1210\/jc.2007-1188","volume":"92","author":"LJ Moran","year":"2007","unstructured":"Moran LJ, Noakes M, Clifton PM, Norman RJ. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(10):3796\u2013802.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"300_CR34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1472-6483(10)60379-3","volume":"15","author":"S El-Halawaty","year":"2007","unstructured":"El-Halawaty S, Rizk A, Kamal M, Aboulhassan M, Al-Sawah H, et al. Clinical significance of serum concentration of anti-m\u00fcllerian hormone in obese women with polycystic ovary syndrome. Reprod Biomed Online. 2007;15(5):495\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"300_CR35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","volume":"67","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Panidis D. Unravelling the phenotyping map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol. 2007;67(5):735\u201342.","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"300_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijgo.2007.01.005","volume":"97","author":"L Li","year":"2007","unstructured":"Li L, Yang D, Chen X, Chen Y, Feng S, Wang L. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet. 2007;97(2):129\u201334.","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"300_CR37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/GRF.0b013e3180305f7c","volume":"50","author":"MN Menke","year":"2007","unstructured":"Menke MN, Strauss JF. Genetics of polycystic ovarian syndrome. Clin Obs Gyn. 2007;50(1):188\u2013204.","journal-title":"Clin Obs Gyn"},{"issue":"9","key":"300_CR38","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","volume":"23","author":"M Das","year":"2008","unstructured":"Das M, Gillott DJ, Saridogan E, Djahanbakhch O. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary sundrome. Hum Reprod. 2008;23(9):2122\u2013216.","journal-title":"Hum. Reprod."},{"issue":"3","key":"300_CR39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2009.04.021","volume":"94","author":"VP Jovanovic","year":"2010","unstructured":"Jovanovic VP, Carmina E, Lobo RA. Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertil Steril. 2010;94(3):826\u201332.","journal-title":"Fertil. Steril."},{"key":"300_CR40","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/humrep\/dei499","volume":"21","author":"R Fleming","year":"2006","unstructured":"Fleming R, Deshpande N, Traynor I, Yates RW. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-mullerian hormone. Hum Reprod. 2006;21:1436\u201341.","journal-title":"Hum. Reprod."}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-014-0300-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-014-0300-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-014-0300-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T17:31:15Z","timestamp":1565717475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-014-0300-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s10815-014-0300-6","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]}}}